The draft National Medical Device Policy (NMDP) 2015 has been welcomed by the medical device industry which will reflect on the growth of medical device market in India. (Read Also: Statistics & Figures: Medical Device Registration India). The CDSCO is responsible for the registration of medical devices in India. The setting up of autonomous body ‘National Medical Device Authority’ (NMDA) was also given credit by the experts. Rajiv Nath, forum coordinator of AIMED expressed his relief over the move and informed it seems Make in India campaign is not just a slogan. The draft has been made as a favorable one to the domestic industry growth and in the same road of AIMED recommendations. We are waiting for the implementation of the final policy so that the we can finally start developing domestic market”.
The DoP (Department of Pharmaceuticals) released the draft on June 3 2015, keeping the long term demands of medical device industry in mind. It would not only strengthen Make in India campaign and also make medical device industry a strong base. On the another on-going issue of price control of medical devices, AIMED has recommended the government should focus on implementing the existing rules first before starting to work on new rules. “Price control is an important aspect to deal with, but it shouldn’t scare the investors. To start with, the government should follow the provisions under the Consumer Act. We can implement 1% tax on MRP value rather the existing 6% excise duty. The sector should be capped by implementing the theses measures to afford consumer satisfaction.” Rajiv Nath added. (Read Also: Entry Strategies for Foreign Investors in India).
Other News
India Medical Device Pricing Strategy: Ensuring Growth & Affordability
India’s National Pharmaceutical Pricing Authority (NPPA) is developing a specialized India medical device pricing strategy for medical devices, transitioning away from the conventional drug-centric framework. This innovative strategy will incorporate international pricing tactics tailored to […]
Read MoreImports of High-Value Medical Equipment
High-Value Medical Equipment The Central Drugs Standard Control Organization (CDSCO) and the Central Board of Indirect Taxes & Customs have released a new circular, “F.No.401/40/2021-Cus.III,” detailing updated policies on the import of used high-end medical […]
Read MoreSEC Committee: Pioneering Medical Approvals
New important article released by Central Drugs Standard Control Organization (CDSCO) titled “SEC – Special Expert Committee, Medical Devices”. Key highlights include the streamlined processes for CDSCO application evaluations, preparation and significance of briefing materials, […]
Read More
ErlySign Oral Cancer Detection Technology Gets CDSCO Nod
ErlySign, a Nagpur-based biotech startup, has received approval from the Central Drugs Standard Control Organization (CDSCO) to conduct large-scale clinical trials for its novel oral cancer detection technology. The approval for ErlySign follows a rigorous […]
Read MoreAdditional Steps Announced by FDA to Modernize Clinical Trials
The U.S. Food and Drug Administration has made draft guidance available with updated recommendations for good clinical practices (GCPs), which are intended to modernize the clinical trial design and conduct while maintaining data integrity and […]
Read MoreAccreditation and Registration Numbers for Foreign Manufacturers Publication by PMDA
This article deals In accordance with the Pharmaceuticals and Medical Devices Act (PMD Act) of Japan, foreign businesses that wish to produce pharmaceuticals, quackery products, active pharmaceutical ingredients (APIs), or medical devices abroad and import […]
Read MoreBSI New Certification to Mitigate Antimicrobial Resistance Risk in Antibiotic Manufacturing
BSI, the business improvement and standards company, has developed a new certification to mitigate the risk of antimicrobial resistance (AMR) in antibiotic manufacturing. The certification, called the Minimized Risk of Antimicrobial Resistance (AMR) certification, will […]
Read More
TUV SUD Inspects IVD Medical Devices’ Cyber Security
The growing digital connectivity of medical infrastructure is resulting in complicated systems with a plethora of diverse interfaces that are potentially vulnerable to assault. The IVD requires producers to provide proof of cyber security before […]
Read More
